Open AccessManagement of Membranous Nephropathy after MENTOR
Author(s) -
Claire Trivin-Avillach,
Laurence H. Beck
Publication year - 2019
Publication title -
clinical journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.755
H-Index - 151
eISSN - 1555-905X
pISSN - 1555-9041
DOI - 10.2215/cjn.10240819
Subject(s) - membranous nephropathy , medicine , rituximab , nephrotic syndrome , immunology , proteinuria , autoantibody , spontaneous remission , antibody , kidney , pathology , alternative medicine
Membranous nephropathy is a common cause of primary nephrotic syndrome, yet it can be particularly vexing to treat due to its extended duration and uncertainties about the implications of a partial remission. Ten years ago, the phospholipase A2 receptor (PLA2R) was identified as the major target
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom